Lower LRP2 was associated with dedifferentiated subtypes and poorer survival in clear-cell/papillary renal cell carcinoma, papillary thyroid carcinoma, mesothelioma, and invasive breast carcinoma, with methylation-linked repression as a plausible mechanism [8]. This evidence concerns the gene LRP2 and invasive breast carcinoma.